Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of methe Phase 3 EF-14 Clinical Trial(Front. Oncol., (2021), 11, (671972), 10.3389/fonc.2021.671972)

In the original article, there was a mistake in Figure 1 as published. An entry was labelled as “No adherence” rather than “Disease progression”. The corrected Figure 1 appears below. In the original article, there was also a mistake in Table 2 as published. Incorrect data appears for Duration of TTFields therapy, months, median (range) and TTFields daily usage ≥75%, n (%) for TTFields plus TMZ. The corrected Table 2 appears below. In the original article, there was a further mistake in Figure 3C as published. There was an error in KPS, median (range) for TTFields (200 kHz) ≥75% Daily Usage. The corrected Figure 3 appears below. The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.